These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10069259)

  • 1. A case-cohort study on prostate cancer risk in relation to family history of prostate cancer.
    Schuurman AG; Zeegers MP; Goldbohm RA; van den Brandt PA
    Epidemiology; 1999 Mar; 10(2):192-5. PubMed ID: 10069259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal products, calcium and protein and prostate cancer risk in The Netherlands Cohort Study.
    Schuurman AG; van den Brandt PA; Dorant E; Goldbohm RA
    Br J Cancer; 1999 Jun; 80(7):1107-13. PubMed ID: 10362125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study.
    van den Brandt PA; Zeegers MP; Bode P; Goldbohm RA
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):866-71. PubMed ID: 14504196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical activity and the risk of prostate cancer in the Netherlands cohort study, results after 9.3 years of follow-up.
    Zeegers MP; Dirx MJ; van den Brandt PA
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1490-5. PubMed ID: 15941961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
    Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
    Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of physical activity and incident and fatal prostate cancer.
    Giovannucci EL; Liu Y; Leitzmann MF; Stampfer MJ; Willett WC
    Arch Intern Med; 2005 May; 165(9):1005-10. PubMed ID: 15883238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of cruciferous vegetables and prostate cancer.
    Giovannucci E; Rimm EB; Liu Y; Stampfer MJ; Willett WC
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1403-9. PubMed ID: 14693729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelation of energy intake, body size, and physical activity with prostate cancer in a large prospective cohort study.
    Platz EA; Leitzmann MF; Michaud DS; Willett WC; Giovannucci E
    Cancer Res; 2003 Dec; 63(23):8542-8. PubMed ID: 14679023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin use in relation to risk of prostate cancer.
    Leitzmann MF; Stampfer MJ; Ma J; Chan JM; Colditz GA; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1108-11. PubMed ID: 12376516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin drugs and risk of advanced prostate cancer.
    Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
    J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men.
    Kurahashi N; Iwasaki M; Sasazuki S; Otani T; Inoue M; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):538-45. PubMed ID: 17337648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study.
    Schuurman AG; van den Brandt PA; Dorant E; Brants HA; Goldbohm RA
    Cancer; 1999 Sep; 86(6):1019-27. PubMed ID: 10491529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary acrylamide intake and prostate cancer risk in a prospective cohort of Swedish men.
    Larsson SC; Akesson A; Wolk A
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1939-41. PubMed ID: 19505926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age specific risks of familial prostate carcinoma: a basis for screening recommendations in high risk populations.
    Grönberg H; Wiklund F; Damber JE
    Cancer; 1999 Aug; 86(3):477-83. PubMed ID: 10430256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis.
    Zeegers MP; Jellema A; Ostrer H
    Cancer; 2003 Apr; 97(8):1894-903. PubMed ID: 12673715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
    Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
    J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey.
    Hawk E; Breslow RA; Graubard BI
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):523-7. PubMed ID: 10815699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial aspects of prostate cancer: a case control study.
    Keetch DW; Rice JP; Suarez BK; Catalona WJ
    J Urol; 1995 Dec; 154(6):2100-2. PubMed ID: 7500468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Height-related risk factors for prostate cancer.
    Norrish AE; McRae CU; Holdaway IM; Jackson RT
    Br J Cancer; 2000 Jan; 82(1):241-5. PubMed ID: 10638996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.